Page 1012 - Williams Hematology ( PDFDrive )

986 Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells CHAPTER 64: Classification and Clinical Manifestations of Neutrophil Disorders 987

32. Koenig JM, Christensen RD: Incidence, neutrophil kinetics and natural history of neo- 70. Ogershok PR, Hogan MB, Welch JE, et al: Spectrum of illness in pediatric common
natal neutropenia associated with maternal hypertension. N Engl J Med 321:557, 1989. variable immunodeficiency. Ann Allergy Asthma Immunol 97:653, 2006.
33. Tsao PN, Teng RJ, Tang JR, Yau KI: Granulocyte colony-stimulating factor in the cord 71. Tamura H, Okamoto M, Yamashita T, et al: Pure white cell aplasia: Report of the first
blood of premature neonates born to mothers with pregnancy-induced hypertension. J case associated with primary biliary cirrhosis. Int J Hematol 85:97, 2007.
Pediatr 135:56, 1999. 72. Zachee P, Daeleans R, Pollaris P, et al: Neutrophil adhesion molecules in chronic hemo-
34. Menasche G, Fischer A, de Saint Basile G: Griscelli syndrome types 1 and 2. Am J Hum dialysis patients. Nephron 68:192, 1994.
Genet 71:1237, 2002. 73. Levitt LJ, Ries CA, Greenberg PL: Pure white-cell aplasia. Antibody-mediated autoim-
35. Kuijpers TW, Maianski NA, Tool AT, et al: Apoptotic neutrophils in the circulation of mune inhibition of granulopoiesis. N Engl J Med 308:1141, 1983.
patients with glycogen storage disease type 1b (GSD1b). Blood 101:5021, 2003. 74. Chakupurakal G, Murrin RJ, Neilson JR: Prolonged remission of pure white cell aplasia
36. Shotelersuk V, Dell’Angelica EC, Hartnell L, et al: A new variant of Hermansky-Pud- (PWCA), in a patient with CLL, induced by rituximab and maintained by continuous
lak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med oral cyclosporin. Eur J Haematol 79:271, 2007.
108:423, 2000. 75. Marmont AM, Dominietto A, Gualandi F, et al: Pure white cell aplasia (PWCA) relaps-
37. Huizing M, Scher CD, Strovel E, et al: Nonsense mutations in ADTB3A cause complete ing after allogeneic BMT and successfully treated with nine DLIs. Biol Blood Marrow
deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak Transplant 12:987, 2006.
syndrome type 2. Pediatr Res 51:150, 2002. 76. Joyce RA, Boggs DR, Hasiba U, Srodes CH: Marginal neutrophil pool size in normal
38. Devriendt K, Kim AS, Mathijs G, et al: Constitutively activating mutation in WASP subjects and neutropenic patients as measured by epinephrine infusion. J Lab Clin Med
causes X-linked severe congenital neutropenia. Nat Genet 27:313, 2001. 88:614, 1976.
39. Vial T, Gallant C, Choqu-Kastylevsky G, Descotes J: Treatment of drug-induced agran- 77. Carr ME, Whitehead J, Carlson P, et al: Case report: Immunoglobulin M-mediated,
ulocytosis with haematopoietic growth factors: A review of the clinical experience. Bio- temperature-dependent neutrophil agglutination as a cause of pseudoneutropenia. Am
Drugs 11:185, 1999. J Med Sci 311:92, 1996.
40. Andersohn F, Konzen C, Garbe E: Systematic review: Agranulocytosis induced by non- 78. Esposito D, Chouinard G, Hardy P, Corruble E: Successful initiation of clozapine treat-
chemotherapy drugs. Ann Intern Med 146:657, 2007. ment despite morning pseudoneutropenia. Int J Neuropsychopharmacol 9:489, 2006.
41. Crawford J, Dale DC, Kuderer NM, et al: Risk and timing of neutropenic events in adult 79. Herring WB, Smith LG, Walker RI, Herion JC: Hereditary neutrophilia. Am J Med
cancer patients receiving chemotherapy: The results of a prospective nationwide study 56:729, 1974.
of oncology practice. J Natl Compr Canc Netw 6:109, 2008. 80. Wiedmeier SE, Henry E, Christensen RD: Hematological abnormalities during the first
42. Flanagan RJ, Dunk L: Haematological toxicity of drugs used in psychiatry. Hum Psy- week of life among neonates with trisomy 18 and trisomy 13: Data from a multi-hospi-
chopharmacol 23(Suppl 1):27, 2008. tal healthcare system. Am J Med Genet A 146:312, 2008.
43. Dale DC, Hammond WP: Cyclic neutropenia: A clinical review. Blood Rev 2:178, 1988. 81. Ward HN, Reinhard EH: Chronic idiopathic leukocytosis. Ann Intern Med 75:193,
44. Horwitz MS, Duan Z, Korkmaz B, et al: Neutrophil elastase in cyclic and severe congen- 1971.
ital neutropenia. Blood 109:1817, 2007. 82. Joyce RA, O’Donnell J, Sanghvi J, Westerman MP: Asplenia and abnormal neutrophil
45. Hutchinson R, Bunnell K, Thorne J: Suppression of granulopoietic progenitor cell pro- kinetics in chronic idiopathic neutrophilia. Am J Med 69:633, 1980.
liferation by metabolites of the branched-chain amino acids. J Pediatr 106:62, 1985. 83. Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H: An update on the eti-
46. Andrès E, Maloisel F: Idiosyncratic drug-induced agranulocytosis or acute neutrope- ology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med 17:394, 2006.
nia. Curr Opin Hematol 15:15, 2008. 84. Reding MT, Hibbs JR, Morrison VA, et al: Diagnosis and outcome of 100 consecutive
47. Andrès E, Federici L, Weitten T, et al: Recognition and management of drug-induced patients with extreme granulocytic leukocytosis. Am J Med 104:12, 1998.
blood cytopenias: The example of drug-induced acute neutropenia and agranulocyto- 85. Marsh JC, Boggs DR, Cartwright GE, Wintrobe MM: Neutrophil kinetics in acute
sis. Expert Opin Drug Saf 7:481, 2008. infection. J Clin Invest 46:1943, 1967.
48. Chuang VW, Wong TY, Leung YH, et al: Review of dengue fever cases in Hong Kong 86. Jardin F, Vasse M, Debled M, et al: Intense paraneoplastic neutrophilic leukemoid reac-
during 1998 to 2005. Hong Kong Med J 14:170, 2008. tion related to a G-CSF-secreting lung sarcoma. Am J Hematol 80:243, 2005.
49. Cutting HO, Lange JE: Familial-benign chronic neutropenia. Ann Intern Med 61:876, 87. Nara T, Hayakawa A, Ikeuchi A, et al: Granulocyte colony-stimulating factor-produc-
1964. ing cutaneous angiosarcoma with leukaemoid reaction arising on a burn scar. Br J Der-
50. Kyle RA: Natural history of chronic idiopathic neutropenia. N Engl J Med 302:908, matol 149:1273, 2003.
1970. 88. Sato T, Omura M, Saito J, et al: Neutrophilia associated with anaplastic carcinoma of the
51. Yilmaz D, Ritchey AK: Severe neutropenia in children: A single institutional experi- thyroid. Thyroid 10:1113, 2000.
ence. J Pediatr Hematol Oncol 29:513, 2007. 89. Sevastos N, Theodossiades G, Malaktari S, Archimandritis AJ: Persistent neu-
52. Vlacha V, Feketea G: The clinical significance of non-malignant neutropenia in hospi- trophilia as a preceding symptom of pheochromocytoma. J Clin Endocrinol Metab
talized children. Ann Hematol 86:865, 2007. 90:2472, 2005.
53. Wlodarski MW, Nearman Z, Jiang Y, et al: Clonal predominance of CD8(+) T cells in 90. Bishop CR: Leukokinetic studies: XIII. A non-steady state kinetic evaluation of the
patients with unexplained neutropenia. Exp Hematol 36:293, 2008. mechanism of cortisone-induced granulocytosis. J Clin Invest 47:249, 1968.
54. Maheshwari A, Christensen RD, Calhoun DA: Immune neutropenia in the neonate. 91. Crockard AD, Boylan MT, Droogan AG, et al: Methylprednisolone-induced neutrophil
Adv Pediatr 49:317, 2002. leukocytosis-down-modulation of neutrophil L-selectin and Mac-1 expression and
55. Williams BA, Fung YL: Alloimmune neonatal neutropenia: Can we afford the conse- induction of colony-stimulating factor. Int J Clin Lab Res 28:110, 1998.
quences of a missed diagnosis? J Paediatr Child Health 42:59, 2006. 92. Murphy DL, Goodwin FK, Bunney WE: Leukocytosis during lithium treatment. Am J
56. Bux J: Human neutrophil alloantigens. Vox Sang 94:277, 2008. Psychiatry 127:135, 1971.
57. Marmont AM: The autoimmune myelopathies. Semin Hematol 28:269, 1991. 93. Salloum E, Stoessel KM, Cooper DL: Hyperleukocytosis and retinal hemorrhages after
58. Bux J, Behrens G, Jaeger G, Welte K: Diagnosis and clinical course of autoimmune neu- chemotherapy and filgrastim administration for peripheral blood progenitor cell mobi-
tropenia in infancy: Analysis of 240 cases. Blood 91:181, 1998. lization. Bone Marrow Transplant 21:835, 1998.
59. Capsoni F, Sarzi-Puttini P, Zanella A: Primary and secondary autoimmune neutrope- 94. de Oliveira JP, Levy A, Morel P, Guibal F: Severe neutrophilia induced by infliximab for
nia. Arthritis Res Ther 7:208, 2005. psoriasis. Br J Dermatol 158:200, 2008.
60. Winkelstein A, Kiss JE: Immunohematologic disorders. JAMA 278:1982, 1997. 95. Kratz A, Lewandrowski KB, Siegel AJ: Effect of marathon running on hematologic
61. Bowman SJ: Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol
31:251, 2002. 118:856, 2002.
62. Burks EJ, Loughran TP Jr: Pathogenesis of neutropenia in large granular lymphocyte 96. Laing SJ, Jackson AR, Walters R, et al: Human blood neutrophil responses to prolonged
leukemia and Felty syndrome. Blood Rev 20:245, 2006. exercise with and without a thermal clamp. J Appl Physiol 104:20, 2008.
63. Prochorec-Sobieszek M, Rymkiewicz G, Makuch-asica H, et al: Characteristics of T-cell 97. Cohen PR: Sweet’s syndrome—A comprehensive review of an acute febrile neutrophilic
large granular lymphocyte proliferations associated with neutropenia and inflamma- dermatosis. Orphanet J Rare Dis 2:34, 2007.
tory arthropathy. Arthritis Res Ther 10:R55, 2008. 98. Ratzinger G, Burgdorf W, Zelger BG, Zelger B: Acute febrile neutrophilic dermatosis: A
64. Beyan E, Beyan C, Turan M: Hematological presentation in systemic lupus erythemato- histopathologic study of 31 cases with review of literature. Am J Dermatopathol 29:125,
sus and its relationship with disease activity. Hematology 12:257, 2007. 2007.
65. Chen M, Zhao MH, Zhang Y, Wang H: Antineutrophil autoantibodies and their target 99. Petitti DB, Kipp H: The leukocyte count: Association with intensity of smoking and
antigens in systemic lupus erythematosus. Lupus 13:584, 2004. persistence of effect after quitting. Am J Epidemiol 123:89, 1986.
66. Mathieson PW, O’Neill JH, Durrant STS, et al: Antibody-mediated pure neutrophil 100. Iho S, Tanaka Y, Takauji R, et al: Nicotine induces human neutrophils to produce IL-8
aplasia, recurrent myasthenia gravis and previous thymoma. Q J Med 74:57, 1990. through the generation of peroxynitrate and subsequent activation of NF-kappaB. J
67. Brito-Zerón P, Soria N, Muñoz in S, et al: Prevalence and clinical relevance of autoim- Leukoc Biol 74:942, 2003.
mune neutropenia in patients with primary Sjögren’s syndrome. Semin Arthritis Rheum 101. Fung YL, Silliman CC, Minchinton RM, et al: Cardiopulmonary bypass induces endur-
38:389, 2009. ing alterations to host neutrophil physiology: A single-centre longitudinal observa-
68. Cuadrado A, Aresti S, Cortés MA, et al: Autoimmune hepatitis and agranulocytosis. tional study. Shock 30:642, 2008.
Dig Liver Dis 41:e14, 2009. 102. Bishop CR, Athens JW, Boggs DR, et al: Leukokinetic studies XIII. A non-steady-state
69. Stevens C, Peppercorn MA, Grand RJ: Crohn’s disease associated with autoimmune kinetic evaluation of the mechanism of cortisone-induced granulocytosis. J Clin Invest
neutropenia. J Clin Gastroenterol 13:328, 1991. 47:249, 1968.

Kaushansky_chapter 64_p0983-0990.indd 987 9/17/15 3:28 PM